One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1136/lupus-2016-000163
Copy DOI Journal: Lupus Science & Medicine |  Publication Date: Sep 1, 2016 |
 Citations: 53 |  License type: open-access |
Affiliation: Karolinska University Hospital, Karolinska Institutet, Charité - Universitätsmedizin Berlin, Copenhagen University Hospital, University of Copenhagen, Rigshospitalet, University College London, Hospital Universitari i Politècnic La Fe, Hospital Universitario Miguel Servet, Istanbul University, University of Szeged, University of Florence, Institut Polytechnique de Paris, Inserm, University of Paris-Sud, Leiden University Medical Center, National and Kapodistrian University of Athens, BioCruces Health research Institute, University of the Basque Country, Hospital de Cruces, San Camillo IRCCS di Venezia, Università Cattolica del Sacro Cuore, Amsterdam UMC Location VUmc, University of Debrecen, Skåne University Hospital, Instituto de Investigación Biosanitaria, Hospital Universitario Virgen de las Nieves, Central University Hospital of Asturias, University of Padua, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Universitari Sant Joan de Reus, Institut d'Investigació Sanitària Pere Virgili, Rovira i Virgili University, University of Pisa, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Hospital de Sabadell, Autonomous University of BarcelonaObjectivesRituximab (RTX) is a biological treatment used off-label in patients with systemic lupus erythematosus (SLE). This survey aimed to investigate the off-label use of RTX in Europe and compare the...
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
